HOME >> BIOLOGY >> NEWS
Studies show success of Mectizan partnerships

The development of the drug Mectizan (ivermectin) and its distribution worldwide have radically altered the consequences of onchocerciasis, or river blindness, which once blinded millions in Africa, and Latin America. Researchers at the Johns Hopkins Bloomberg School of Public Health conducted four new studies evaluating the Mectizan Donation Program, which was established by Merck and Co. Inc., the makers of Mectizan. They concluded that the now 17-year old Mectizan Donation Program is a successful and cost effective program for preventing the debilitating effects of river blindness. The researchers also believe that the public-private partnership forged by Merck through the Mectizan Donation Program should serve as a model for other companies and aid organizations seeking to prevent and treat other illnesses worldwide, such as AIDS and malaria. The studies are published in the current issue the journal Tropical Medicine and International Health.

On May 14, 2004, the School of Public Health and Merck and Co. Inc., will mark the successful work of the Mectizan Distribution Program with a symposium, "Controlling River Blindness: Achievements of a Public-Private Partnership." The event will be held from 12:15-1:30 p.m. at the School of Public Health in Baltimore, Md. and will feature discussions of the latest study findings from researchers from the School of Public Health and representatives from Merck and the Mectizan Donation Program.

"The Mectizan Donation Program is really one of the great public health success stories. It is the benchmark for all other disease prevention efforts in the developing world," said Gilbert Burnham, MD, one of the study authors and an associate professor in the School's Department of International Health.

Ivermectin, the compound from which Mectizan is derived, was originally found to be effective against parasites in farm animals. Realizing its potential as a human medicine, Merck and WHO conducted seven years of
'"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
10-May-2004


Page: 1 2

Related biology news :

1. Monkey business: Studies show tiny callimicos have unusual characteristics
2. Studies offer new insight into HIV vaccine development
3. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
4. Studies show preventive value of food supplements
5. Studies probe rapid evolution of Chinese tallow trees
6. Studies of rare blood syndrome yield novel route to cancer
7. Studies dispute ultraviolet effect on amphibian population declines
8. Studies of spiders silk reveal unusual strength
9. Studies of genes in mice and common worm may accelerate research on blood diseases, cancers
10. Studies offer data on potential impact of Reminyl on caregiver burden in Alzheimers disease
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... ... October 18, 2018 , ... Drug toxicity is a pervasive issue in the ... and mitigated. Failure to recognize such toxicities during the course of drug development ... serious challenge to drug developers faced with an unforeseen drug withdrawal from the market. ...
(Date:10/18/2018)... ... October 18, 2018 , ... Protein derived from cottonseed for ... approval , Writer: Kay Ledbetter, 806-677- 5608, skledbetter@ag.tamu.edu, Dr. Keerti Rathore, 979-862-4795, rathore@tamu.edu ... project to which Dr. Keerti Rathore has devoted more than half his professional ...
(Date:10/16/2018)... ORANGE, N.J. (PRWEB) , ... October 16, 2018 , ... ... and repairing damaged discs in our spine. , So comments interventional spine and pain ... rich in antibodies, enzymes and proteins, or stem cells harvested from a patient’s bone ...
Breaking Biology News(10 mins):
(Date:10/13/2018)... ... October 12, 2018 , ... The ... innovation and commercialization, celebrates its 50th birthday in New York’s Times Square today, ... Electro-Optics (ICALEO) conference. , In celebration of its 50 years, LIA showed ...
(Date:10/5/2018)... ... October 04, 2018 , ... Power T ... Spine Technology Award from Orthopedics This Week during the 2018 National Association of ... Handle is a surgical instrument that delivers operating room efficiencies through increased speed ...
(Date:10/3/2018)... ... October 03, 2018 , ... Milwaukee Area Technical College (MATC), a public, two-year ... 3-7 p.m. in Room T129 in the T Building, 101 N. 6th St., to ... A ribbon cutting and formal program will be held at 4 p.m. , MATC ...
(Date:10/2/2018)... CAMBRIDGE, Mass. (PRWEB) , ... October 02, 2018 ... ... ( ACRES ) announced this week that teams have initiated validation of standards ... evaluation effort, under the direction of Dr. Larry Kennedy, ACRES VP for Quality ...
Breaking Biology Technology:
Cached News: